ReviewCurrent neuropharmacology2025
The Role of Epigenetics in the Pathogenesis and Potential Treatment of Obsessive-compulsive Disorder.
Review in Current neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obsessive-compulsive disorder is a common neuropsychiatric disorder that markedly affects the quality of life of affected patients. There is increasing evidence that abnormal epigenetic mechanisms of gene expression are involved in the pathogenesis of this disorder. This article reviews the available data on epigenetic abnormalities found in patients with this disorder. The article also reviews the data on the use of epigenetic therapy in the treatment of obsessive-compulsive disorder, and epigenetic changes noted during psychotherapy of patients with this disorder. More detailed knowledge of the role of abnormal epigenetic mechanisms underlying obsessive-compulsive disorder could facilitate the development of new drugs for treating this disorder and the development of biomarkers for this disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.